Publication & Citation Trends
Publications
46 total
Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors PDF
Cited by 25
OpenAlex
Clinical usefulness of 2-hydroxyglutarate as a biomarker in IDH-mutant chondrosarcoma PDF
Cited by 14
OpenAlex
Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma PDF
Cited by 69
OpenAlex
A Potent Blood–Brain Barrier-Permeable Mutant IDH1 Inhibitor Suppresses the Growth of Glioblastoma with IDH1 Mutation in a Patient-Derived Orthotopic Xenograft Model PDF
Cited by 53
OpenAlex
Dual inhibition of enhancer of zeste homolog 1/2 overactivates <scp>WNT</scp> signaling to deplete cancer stem cells in multiple myeloma PDF
Cited by 25
OpenAlex
Research Topics
Glioma Diagnosis and Treatment
(22)
Histone Deacetylase Inhibitors Research
(12)
Epigenetics and DNA Methylation
(11)
Cancer, Hypoxia, and Metabolism
(6)
Metabolomics and Mass Spectrometry Studies
(5)
Affiliations
Piedmont Athens Regional
University of Georgia
Kyoto University
National Cancer Centre Japan
BioChem Technology (United States)